In some cases, a minority of cells called TICs, or cancer stem cells, are culpable of repopulating
the tumor after therapy.
These cancer stem cells act like the seeds of cancer and are responsible for re-growing
a tumor after therapy.
Not exact matches
The FDA approved a Lutetium - 177 based cancer
therapy called Lutathera for the treatment of neuroendocrine
tumors earlier this year,
after Novartis snapped up the developer, Advanced Accelerator, at a premium.
Some weeks later,
after radiation
therapy that was designed to limit the extent of the surgery, he wrote to tell me that the doctors were astounded to learn that the
tumor had been stopped cold by the radiation and that surgery would not be required.
This study analyzed preserved
tumor samples from 43 prostate cancer patients who later received radiation
therapy after rising PSA levels were detected following a radical prostatectomy.
In particular, the study suggests that two miRNAs — miR - 4516 and miR - 601 — in
tumor cells along with Gleason score and lymph node status may help identify patients who might experience rising PSA
after they've been treated with radiation
therapy.
To uncover how this resistance occurs, Guo and Lu teamed with Xu, Herlyn and colleagues examined both cell lines and
tumor biopsies from melanoma patients before and
after either BRAF inhibitor
therapy or BRAF / MEK inhibitor combination
therapy.
With these in vitro test methods, the KU researchers have shown that anti-CD44s antibody can reduce pancreatic cancer cell growth, metastasis and ability of the
tumors to recur
after radiation
therapy.
Now that we know more about how cancer originates and how
tumors re-grow
after treatment, we can design new
therapies to prevent this.
«In order to block
tumor recurrence
after radiation
therapy, we used an antibody to target and inhibit these cancer stem cells,» said Dr. Xu.
Glioblastoma accounts for about 15 percent of all brain
tumors, is resistant to current
therapies and has a survival as short as 15 months
after diagnosis.
While the patient eventually relapsed and died more than a year
after CAR T - cell
therapy, the brain
tumor never recurred.
In addition, when a subcutaneous
tumor began to recur two months
after CAR T - cell
therapy and a surgical biopsy was performed, the CAR T - cells spontaneously re-expanded and the
tumor again went into remission, and phenomenon that had not previously been reported.
The study, which followed four individuals for a year
after they were treated with embryonic stem cell - derived retinal pigment epithelial cells for macular degeneration, observed no serious side effects (
tumor growth or other unexpected effects) related to the
therapy.
He says that if future trials are successful, the experimental vaccine, which can be made relatively quickly and cheaply, could become a short - term
therapy administered immediately
after diagnosis to try to keep
tumors in check.
«We identified patients who had both contrast - enhanced digital mammography and MRI
after treatment to shrink their
tumors and before additional
therapy or a mastectomy.»
Oncologists have long known that in rare cases,
after patients receive radiation
therapy to shrink a
tumor, the immune system will mount an aggressive response that wipes out not only the
tumor, but metastases throughout the body that hadn't been treated with the radiation.
If it proves as effective in people as it is in mice, a vaccine could one day be given to cancer patients
after surgery, radiation
therapy, or chemotherapy to prevent
tumors from regrowing.
Their latest pledge came
after Druker recently lobbied the couple for another $ 1 billion to take insights from Gleevec, as well as other so - called molecularly targeted
therapies, and develop better early detection tools for
tumors.
tumors from neural stem cells also contained more glioblastoma stem cells, cells that are believed to give rise to
tumor recurrence
after therapy,» says Lene Uhrbom, senior lecturer at the Department of Immunology, Genetics and Pathology and lead author of the study.
After four cycles of
therapy (42 days), all mice receiving the combined regimen were alive, whereas mice in the other groups had to be euthanized due to
tumor growth.
Type I
tumors are often treated with radiation
therapy, which helps stop or slow cancer growth, given in addition to or
after the primary treatment.
After enrolling in a clinical trial for genetically based drug
therapy, Victor's
tumor has shrunk and shows no signs of growth.
Although there is currently no technology that allows early diagnosis of the disease, a number of putative markers have been identified: their detection
after diagnosis would be a useful tool to monitor the evolution of the
tumor during treatment, providing valuable prognostic information on response to a given
therapy.
In the next year, members of the Dream Team will continue to study the
tumor microenvironment before and
after checkpoint blockade, to develop algorithms to identify and predict the best antigens on cancer cells that can be used for cancer immunotherapies, to analyze
tumor tissues and blood for biomarkers that will help in selecting patients who will benefit, and identifying the best approaches to increase the strength of immune cells for adoptive cell
therapy.
University of Texas M.D. Anderson Cancer Center
Tumor - specific alloantigen - anergic donor - derived T - cell
therapy after hematopoietic stem - cell transplantation
Discovery of actionable
therapy targets in drug - resistant breast
tumors after neoadjuvant
therapy
Advanced Cancers Destined to Return
After Single Drug
Therapies Targeted cancer cell therapies using man - made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease
Therapies Targeted cancer cell
therapies using man - made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease
therapies using man - made proteins dramatically shrink many
tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Radiation
Therapy Prolongs Life in Men with Recurrent Prostate Cancer Men whose
tumors recur
after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two years of the recurrence.
Positron emission tomography (PET) imaging of metabolic
tumor burden at diagnosis and
after induction
therapy can help identify patients most at risk of follicular lymphoma (FL) recurrence, but more work is needed to differentiate high - risk and moderate - risk patients, suggested findings from a pooled analysis of data from three prospective clinical trials, published in Blood.
Researchers at The McDonnell Genome Institute at the School of Medicine have co-led a study on breast
tumors — before and
after hormone reduction
therapy.
Slow down lymphoma growth modestly and show no effect on
tumor regression; delay
tumor recurrence with activation of p53; enhance
tumor regression and inhibit
tumor recurrence
after alkylating drug
therapy.
«The risk of breast cancer does decline
after stopping hormone
therapy,» she stresses, «but if a
tumor has formed while a woman is on hormones its very likely to come to light even
after she stops hormones, so there is some residual risk.
Another study published in the Journal of Cancer Science and
Therapy found that
after just 30 days of infrared treatment,
tumor - infected mice saw up to 86 % reductions!
Until then, chemotherapy and radiation
therapy were the two main solutions offered
after removal of cancerous
tumors, just like in people.
For instance,
after a
tumor has been surgically removed, laser
therapy can reduce pain and speed up the recovery time.
If the
tumor is shrinking or remaining stable in size
after 4 - 8 weeks, and the dog is feeling well on that
therapy, then the same treatment is continued.
Surgical treatment to remove the
tumors is the optimal
therapy and the largest reported series of cases to date demonstrated a mean survival time
after surgery of around 500 days, which is relatively long given that affected ferrets are usually middle - aged at the time of diagnosis.
For dogs with Grade I and II
tumors, recovery is excellent
after surgical removal and radiation
therapy.
If the
tumor can not be completely surgically removed, your veterinarian may recommend radiation
therapy after surgery, which has been shown to be very effective in reducing the size of the
tumor.
Meta - Analysis to Determine the Diagnostic Value of 2 - 18Fluoro -2-Deoxy-D-Glucose Positron Emission Tomography in Assessing Residual
Tumors after Systemic
Therapy for Metastatic Seminoma